GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of week 11 check-in — 31kg down, muscle cramps manageable, one thing confusing me — 54 comments in the full submission. View in context.
2k
c/retatrutide·submitted 11 months ago by u/solene_ilunga

week 11 check-in — 31kg down, muscle cramps manageable, one thing confusing me

Cautionbranch of 10 comments

Genuinely asking, not being difficult. Everyone in c/newbiequestions repeats that dose escalation is important. I believe it, but I have never seen anyone show why, and when I search I get 2 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is…

Read the full submission and all 54 comments →

This branch

10 comments, started 11 months ago
u/hassan_nilsen166 points·11 months ago

The heart rate signal in TRIUMPH is real and concerning. Higher doses had higher mean HR changes.

replysharereportpermalink
u/incretin_ivyMOD120 points·11 months ago

Tracking number removed. It identifies both ends of a shipment.

replysharereportpermalink
u/honest_syringe_202582 points·11 months ago

the weight curves are unusually steep, which makes predicting individual response harder

replysharereportpermalink
u/solene_ilunga50 points·11 months ago

That is net peptide content, not purity. Different number, different meaning.

replysharereportpermalink
u/solene_ilungaOP35 points·11 months ago

triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual

replysharereportpermalink
u/ewan_marchand8 points·11 months ago

nobody should be giving this to anyone without extensive monitoring

replysharereportpermalink
u/careful_gradient3251 points·11 months ago

the weight curves are unusually steep, which makes predicting individual response harder

replysharereportpermalink
u/farid_molnar28 points·11 months ago

triple agonism is glucagon, do not generalise

replysharereportpermalink
u/zeynep_mbeki23 points·11 months ago

triple agonism is glucagon, do not generalise

Yes, exactly this, and it is the bit that took me 24 weeks to accept.

replysharereportpermalink
u/lina_bruun-33 points·11 months ago

Not convinced. The evidence does not support that reading.

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.